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Separation of nonsteroidal anti-inflammatory drugs
by capillary electrophoresis using nonaqueous
electrolytes
The aim of the present work was to investigate the separation of nonsteroidal anti-
inflammatory drugs (NSAIDs: niflumic acid, flufenamic acid, piroxicam, alclofenac, tiap-
rofenic acid, flurbiprofen, suprofen, ketoprofen, naproxen, indomethacin, carprofen,
indoprofen, sulindac) in capillary electrophoresis (CE) using completely nonaqueous
systems. The influence of different parameters such as nature and proportion of
organic solvent (methanol, acetonitrile, 2-propanol), apparent pH (ranging from 7 to 9)
and temperature (ranging from 25 to 40oC) on selectivity and migration times were
studied systematically in an uncoated fused-silica capillary. A nonaqueous electrolyte
made of 50 mM ammonium acetate – 13.75 mM ammonia in methanol proved to resolve
11 NSAIDs at 25oC and 13 NSAIDs at 36oC, both within 13 min and without a modifier
besides the methanol itself. The same buffer containing 30% acetonitrile provides a
satisfactory separation for 13 NSAIDs within 14 min at 25oC.











Capillary electrophoresis (CE) has been used increas-
ingly as separating analytical method over the last ten
years. So far, the majority of CE separations have been
realized in aqueous media. Organic solvents have been
used extensively in micellar electrokinetic chromatogra-
phy (MEKC) [1–4] and in capillary electrochromatography
(CEC) [5, 6], most often to improve the separation of
hydrophobic compounds. The use of nonaqueous electro-
lyte has gained attention in various publications because
of the better solubility of hydrophobic analytes [7–23].
Already in 1984, a separation in an acetonitrile buffer con-
taining hydrochloric acid and tetraethylammonium per-
chlorate was described by Walbroehl, for the analysis of
quinoline derivatives [7]. Benson et al. used nonaqueous
electrolytes containing ammonium acetate and acetic acid
in methanol for the CE separation of hydrophobic metabo-
lites of the antitumor drug pyrazoloacridine [8] and of the
H2 antagonist mifentidine [9, 10]. Tamoxifen and its
metabolites have been separated using a mixture of
methanol and acetonitrile (50:50) containing ammonium
acetate [11]. Sahota and Khaledi [12] reported a separa-
tion of peptides in formamide.
Bjørnsdottir and Hansen have obtained important se-
lectivity changes by using different organic solvents (for-
mamide, N-methylformamide, N,N-dimethylformamide,
dimethylsulfoxide, methanol, and acetonitrile) as separa-
tion media for cationic compounds, such as tricyclic anti-
depressives [13] and opium alkaloids [14], that would be
difficult to resolve in aqueous buffers.
A tris(hydroxymethyl)aminomethane-acetate buffer in
methanol has been described for the separation of aro-
matic and aliphatic acids [15] and N-methylformamide for
the separation of carboxylic acids [16]. Two papers have
reported the analysis of inorganic anions in nonaqueous
systems, using dimethylformamide [17] and methanol
[15] as organic solvents. The potential of nonaqueous
electrolyte in CE for the separation of hydrophobic solutes
has also been studied by Salimi-Moosavi and Cassidy
[18] for a series of alkanesulfonates (C2–C16), alkylsul-
fates (C8–C18) and linear alkyl benzenesulfonates. Vari-
ous acidic compounds (pharmaceuticals, including chiral
separation of NSAIDs, dyes or surfactants) have been
studied using running electrolyte containing different
ratios of methanol and acetonitrile [20, 22].
Nonaqueous media extended the application range of CE
to the analysis of compounds of poor solubility in water,
and also improved the selectivity of the separation of
compounds, which are characterized by similar electro-
phoretic mobilities in aqueous media. Organic solvents
for separation media in CE are selected according to their
dielectric constant, their viscosity, their UV-absorbance,
and by their capability to increase hydrophobic interac-
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tions between the solvent and the analytes, leading to sig-
nificant changes of the selectivity of analytical separa-
tions. Solvents with high dielectric constants and low vis-
cosity are the most suitable for the composition of buffer
media [19].
Another interesting aspect of nonaqueous electrolytes is
the complete evaporability of these separation media,
which is highly suited to the coupling between CE and
mass spectrometry [8–10]. CE with aqueous buffers con-
taining additives (such as cyclodextrins, cellulose deriva-
tives, surfactants) is not as convenient to mass spectro-
metric detection. Moreover, nonaqueous electrolytes can
be prepared with volatile electrolytes, such as ammonium
acetate, ammonia, or acetic acid. Applications of such
media coupled to mass spectrometry were discussed by
Tomlinson et al. [8–10].
The aim of the present work was to investigate the sepa-
ration of nonsteroidal anti-inflammatory drugs (NSAIDs)
in CE using methanol, acetonitrile, and a mixture of both
as nonaqueous medium. NSAIDs are acidic compounds
characterized by low solubility in water; some have similar
charge densities, which makes their separation difficult in
aqueous systems. The influence of different parameters
such as apparent pH (*pH) and temperature of the buffer
medium were also studied.
2 Materials and methods
2.1 Apparatus
All experiments were performed on a Spectraphoresis
1000 CE instrument (SpectraPhysics, San Jose, CA,
USA) equipped with an automatic injector, an autosam-
pler, a variable wavelength UV-visible absorbance detec-
tor (190–800 nm) and a temperature control system (15–
60oC). An IBM PS/2 Model 90486 was used for instru-
ment control and data handling. Electropherograms were
printed on a Laserjet 4 printer (Hewlett-Packard, Avon-
dale, PA, USA). A capillary cartridge was obtained from
SpectraPhysics and fused-silica capillaries were provided
by Polymicro Technologies (Phoenix, AZ, USA). The pH
and apparent pH (noted *pH) of running buffers were
measured by means of a model Delta 345 pH meter with
a glass electrode from Mettler (Halstead, UK).
2.2 Chemicals and reagents
Methanol of HPLC grade (maximum 0.02% of water) was
obtained from Acros (Geel, Belgium). Ammonium acetate
of analytical grade was purchased from Merck (Darm-
stadt, Germany), as were ammonia, acetic acid and ben-
zylic alcohol of analytical grade. Water was of Milli-Q
quality (Millipore, Bedford, MA, USA). Piroxicam, indo-
methacine, niflumic acid, flufenamic acid, ketoprofen,
suprofen, sulindac, carprofen, indoprofen, flurbiprofen
and naproxen were obtained from Sigma Chemicals (St.
Louis, MO, USA). Alclofenac was obtained from Conti-
nental Pharma (Brussels, Belgium) and tiaprofenic acid
from Roussel (Brussels, Belgium). All drugs were used as
received without further purification. The chemical struc-
tures and the pKa values of these compounds are given in
Fig. 1. All solutions were filtered using polytetrafluoroethy-
lene (PTFE) membranes of 0.22 mm from Schleicher &
Schuell (Dassel, Germany).
2.3 Electrophoretic technique
Electrophoretic separations were carried out with
uncoated fused-silica capillaries having 50 mm internal di-
ameter and 44 cm length (37 cm to the detector). Before
each injection, the capillary was treated successively with
alkaline solutions (1 M NaOH, 0.1 M NaOH), water and
running buffer. At the beginning of each working day, the
capillary was rinsed with running buffer for 10 min. Be-
tween each injection, the capillary was successively
rinsed with water and methanol for 2 min (about four
volumes of capillary), and with buffer for 3 min (about six
volumes of capillary). The optimal separation buffer for
NSAIDs consisted of 50 mM ammonium acetate –
13.75 mM ammonia in different organic solvents, prefera-
bly methanol. The applied voltage was –25 kV (detector
at the anode end of the capillary) for methanolic buffers
and 25 kV (detector at the cathodic end) for aqueous buf-
fers. UV detection was performed at 280 nm. This wave-
length was found to be a good compromise for the detec-
tion of the NSAIDs tested. Injections were made in
hydrodynamic mode for a period of 2 s (corresponding to
5.3 nL). The capillary was thermostated at 25oC, unless
otherwise stated. Test mixtures of NSAIDs were prepared
in methanol, at a concentration of ca. 4 ´ 10–5 M (20 mg/
mL) each. The migration order was determined by injec-
tion of individual solutions of each NSAID at the same
concentration and by spectral comparison. The electroos-
motic flow was measured with a neutral marker (0.01%
solution of benzylic alcohol). The resolution (Rs) and plate
number (N) were calculated according to the standard
expressions based on the peak width at half height [24].
The asymmetry factor (As) was determined using the
expression: As = b/a where a is the distance between the
perpendicular from the peak maximum to the leading
edge of the peak at one-tenth of the peak height and b is
the distance between the perpendicular from the peak
maximum to the trailing edge of the peak at one-tenth of
the peak height.
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3 Results and discussion
3.1 Organic solvent
The influence of the nature and the concentration of
organic solvents was studied first. As can be seen in Fig.
2, the addition of methanol, ethanol and 2-propanol to the
running electrolyte significantly reduced the EOF. Aceto-
nitrile does not have as strong an influence, probably due
to its higher dielectric constant and the lower viscosity of
the mixture. Methanol was also found to provide important
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Figure 1. Chemical structures of NSAIDs and their pKa
values. (1) Alclofenac (pKa 4.6); (2) Carprofen (pKa 4.3);
(3) Flufenamic acid (pKa 3.9); (4) Flurbiprofen (pKa 4.1);
(5) Indomethacin (pKa 4.5); (6) Indoprofen (pKa 5.8);
(7) Ketoprofen (pKa 4.0); (8) Naproxen (pKa 4.2); (9) Niflu-
mic acid; (10) Piroxicam (pKa 6.3); (11) Sulindac
(pKa 4.7); (12) Suprofen (pKa 3.9); (13) Tiaprofenic acid
(pKa 3.0).
changes in selectivity, compared to other solvents tested.
In a completely methanolic system, the cathodic electro-
osmotic flow was strongly decreased in comparison to the
analogous aqueous system (cf. Table 1), because of
changes in the dielectric properties and the viscosity of
the system. The electroosmotic mobility of methanolic
medium was lower than the effective mobilities of
NSAIDs, so that these anionic compounds could not
reach the detector when the latter was located at the
cathodic side of the capillary. Effective mobilities of most
NSAIDs in nonaqueous systems were slightly reduced
compared to those obtained in aqueous systems (Table
1), whereas electroosmotic mobility was strongly de-
creased (meo = 63 ´ 10–5 cm2/Vs in aqueous systems and
meo = 7.5 ´ 10–5 cm2/Vs in methanolic systems).
Consequently, the electroosmotic flow is too low to trans-
port anionic NSAIDs towards the cathode located at the
detector side, as is the case in aqueous systems [25].
Therefore, in methanolic systems the polarity of the elec-
trical field had to be reversed and the NSAIDs were
detected at the anodic end of the capillary. The electroos-
motic flow then moves in the opposite direction.
If the reduction of the electroosmotic flow was the only
effect when methanol was used as separation medium, a
reverse migration order of NSAIDs should be observed,
compared to that in aqueous systems. However, Table 1
shows several significant differences in the migration
order of NSAIDs between the two systems. For example,
sulindac exhibits the lowest effective mobility in both sys-
tems, while alclofenac, which should be the first migrating
peak in methanolic systems (because of its higher effec-
tive mobility), appears as the fourth peak in methanolic
electrolyte. Piroxicam appears among the analytes with a
lower effective mobility in the aqueous system, while it
has one of the highest effective mobilities in the nonaque-
ous system. In the aqueous buffer, a series of compounds
(flufenamic acid, niflumic acid, tiaprofenic acid, flurbipro-
fen, naproxen, carprofen, and ketoprofen) exhibit similar
electrophoretic mobilities and are difficult to resolve under
such conditions. As shown in Table 1, the range of effec-
tive mobilities of NSAIDs is larger in the methanol buffer
than in the aqueous buffer, so that greater differences in
the mobilities of NSAIDs are achieved, particularly for the
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Figure 2. Influence of organic
solvent concentration on elec-
troosmotic mobility (meo). Buffer:
75 mM glycine adjusted to
pH 9.1 with triethanolamine
containing an organic solvent in
different proportions (0–40%).
Voltage, 15 kV. Detection wave-
length, 200 nm. Neutral marker,
0.01% solution of benzylic alco-
hol in water. Organic solvents:
(&) acetonitrile; (*) methanol;
(~) ethanol; (+) 2-propanol.
Table 1. Electroosmotic mobilities and NSAID effective
mobilities in aqueous and nonaqueous systems
Effective mobilities (mep ´ 10–5) cm2/Vs
Aqueous system (1) Nonaqueous system (2)
Alclofenac –28.1 Niflumic acid –26.0
Flufenamic acid –27.0 Flufenamic acid –24.2
Niflumic acid –26.8 Piroxicam –22.8
Tiaprofenic acid –26.5 Alclofenac –22.2
Flurbiprofen –26.4 Tiaprofenic acid –21.6
Naproxen –26.4 Flurbiprofen –21.3
Carprofen –25.8 Ketoprofen –20.7
Ketoprofen –25.5 Naproxen –20.1
Piroxicam –24.0 Indomethacin –19.6
Indomethacin –22.1 Carprofen –18.8
Sulindac –21.3 Sulindac –17.6
Electroosmotic mobilities (meo ´ 10–5) cm2/Vs
Aqueous system (1) Nonaqueous system (2)
meo 63.0 meo 7.5
Buffer: 50 mM ammonium acetate – 13.75 mM ammonia
(1) in water or (2) in methanol
Other conditions as described in Section 2.3
group of compounds that are not resolved in the aqueous
buffer. Methanol decreases the effective mobilities of
NSAIDs but also changes the selectivity, depending on
the chemical structure of the analyte. Different solvation
properties of the analytes in this organic solvent can be
made responsible for these changes in selectivity: the
NSAIDs solvated by methanol may have greater differ-
ences in their molecular geometry.
Figures 3 and 4 show the separation of NSAIDs in water
and methanol, respectively; both media have the same
electrolyte composition. Due to the higher electroosmotic
flow in the aqueous system, analysis times are considera-
bly shorter than in methanol. As shown in Fig. 4, a meth-
anol solution of ammonium acetate and ammonia gives
rise to much better selectivity compared to that obtained
in aqueous buffer, so that a baseline separation of eleven
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Figure 3. Separation of NSAIDs
with aqueous buffer. Buffer:
50 mM ammonium acetate
–13.75 mM ammonia (pH 9) in
water. Voltage, 25 kV. Other
conditions as described in Sec-
tion 2.3. Peaks: 1, sulindac;
2, indomethacin; 3, piroxicam;
4–10, unresolved peaks (keto-
profen, carprofen, naproxen,
flurbiprofen, tiaprofenic acid,
niflumic acid; flufenamic acid);
11, alclofenac.
Figure 4. Separation of NSAIDs
with methanolic buffer. Buffer:
50 mM ammonium acetate
–13.75 mM ammonia (*pH 8.5)
in methanol. Voltage: –25 kV.
Other conditions as described in
Section 2.3. Peaks: 1, niflumic
acid; 2, flufenamic acid; 3, pirox-
icam; 4, alclofenac; 5, tiapro-
fenic acid; 6, flurbiprofen;
7, ketoprofen; 8, naproxen;
9, indomethacin; 10, carprofen;
11, sulindac.
NSAIDs could be achieved without addition of any other
component to the running buffer.
As shown in Table 2, high efficiency and excellent peak
symmetry were found for all NSAIDs tested in the nona-
queous methanol system, in spite of a relatively wide
range of migration times. The peaks seem to be less sen-
sitive to deformation due to electromigration dispersion in
such nonaqueous system than with aqueous or mixed
aqueous-organic electrolytes. For the next experiments,
three analytes (indoprofen, suprofen, and fenoprofen)
were added to the previous mixture to compose a more
complex test sample. The influence of gradual replace-
ment of methanol by acetonitrile on the separation of 13
NSAIDs is shown in Fig. 5. A slight increase in migration
times was observed when the concentration of acetoni-
trile was increased. This tendency is certainly related to
the concomitant increase of the electroosmotic flow (meo =
7.5 ´ 10–5 cm2/Vs without acetonitrile and meo = 46 ´ 10–5
cm2/Vs with 90% acetonitrile). This increase in electroos-
motic mobility with acetonitrile concentration can be partly
explained by changes of both viscosity and dielectric con-
stant of the separation buffer.
Some inversions of the migration order occurred when
the concentration of acetonitrile was varied, probably by
changes of solvation of the analytes. The separation of
the critical pair sulindac-indoprofen is improved by this
inversion; it is completely resolved at concentrations
greater than 25% of acetonitrile in the buffer. However,
for several pairs, such as naproxen-indomethacin, alclofe-
nac-tiaprofenic acid and piroxicam-flufenamic acid, which
were baseline-resolved in methanol, the resolution
decreased in buffers with high concentrations of acetoni-
trile. Figure 6 shows a separation of 13 NSAIDs obtained
with a 50 mM ammonium acetate – 13.75 mM ammonia
buffer prepared in 70% methanol and 30% acetonitrile.
Under these conditions, which seem to be the best com-
promise for the model mixture applied, satisfactory sepa-
ration was achieved for most compounds (all compounds
were baseline-resolved except the pair flufenamic acid-
piroxicam).
At high acetonitrile concentrations (above 50%), electro-
osmotic mobility becomes higher than the effective mobili-
ties of NSAIDs, so that the analytes can not reach the
detector at the anodic side. This nonaqueous medium is
less favorable for high resolution than the completely
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Table 2. Efficiency and peak symmetry of NSAIDs in
nonaqueous buffer
Analyte Efficiency (N) Asymmetry factor (As)
Niflumic acid 158 800 1.0
Flufenamic acid 131 200 1.0
Piroxicam 134 500 1.0
Alclofenac 122 300 1.1
Tiaprofenic acid 132 100 1.1
Flurbiprofen 119 600 1.1
Ketoprofen 111 900 1.1
Naproxen 96 200 1.2
Indomethacin 114 000 1.1
Carprofen 94 500 1.0
Sulindac 116 400 1.0
Buffer: 50 mM ammonium acetate – 13.75 mM ammonia
in methanol (*pH 8.5).
Other conditions as described in Section 2.3
Figure 5. Influence of percent-
age of acetonitrile in methanol
on migration times. Buffer:
50 mM ammonium acetate
–13.75 mM ammonia in meth-
anol-acetonitrile in varying pro-
portions (0–40%). Other condi-
tions as described in Section
2.3. Analytes: (^) niflumic acid;
(&) flufenamic acid; (~) piroxi-
cam; (´) alclofenac; ($) tiapro-
fenic acid; (*) flurbiprofen;
(^) suprofen; (+) ketoprofen;
(*) naproxen; (–) indomethacin;
(~) carprofen; (-)indoprofen;
(&) sulindac.
methanolic system, probably due to the high electroos-
motic flow caused by acetonitrile as buffer component.
The corresponding electroosmotic mobility (about 46 ´
10–5 cm2/Vs) is close to that arising in the aqueous sys-
tem (cf. Table 1). Moreover, even if the range of NSAID
migration times is narrower than in methanol, the zones
seem to be more sensitive to deformation due to electro-
migrative dispersion, as can be recognized from the
asymmetry of the peaks. A separating medium with 100%
acetonitrile could not be applied because the solubility of
ammonium acetate is too low.
3.2 Apparent pH (*pH)
As can be seen from Fig. 7, changes in selectivity and in
the migration order of NSAIDs were obtained by changing
the apparent pH of the methanolic electrolyte, while
migration times were not much affected. These changes
could sometimes result in resolution improvement. The
apparent pH was varied by an increasing ammonia con-
centration from 4.5 mM (*pH 8) to 35 mM (*pH 9). *pH 7
and *pH 7.5 were obtained by the addition of 35 and
15 mM of acetic acid, respectively. However, resolution
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Figure 6. Separation of NSAIDs
in a methanolic buffer containing
30% acetonitrile. Buffer: 50 mM
ammonium acetate –13.75 mM
ammonia in methanol/acetoni-
trile (70/30 v/v). Other condi-
tions as described in Section
2.3. Peaks: 1, niflumic acid;
2, flufenamic acid; 3, piroxicam;
4, alclofenac; 5, tiaprofenic acid;
6, flurbiprofen; 7, suprofen;
8, ketoprofen; 9, naproxen;
10, indomethacin; 11, carprofen;
12, indoprofen; 13, sulindac.
Figure 7. Influence of apparent
pH on migration times. Buffer:
50 mM ammonium acetate in
methanol adjusted to *pH 7 with
acetic acid and to *pH 8–9 with
ammonia. Other conditions as
described in Section 2.3. Analy-
tes: (^) niflumic acid; (&) flufe-
namic acid; (~) piroxicam; (´)
alclofenac; ($) tiaprofenic acid;
(*) flurbiprofen; (+) ketoprofen;
(*) naproxen; (–) indomethacin;
(~) carprofen; (&) sulindac.
modifications observed with the apparent pH variation do
not seem to be the only consequence of this increase in
ionic strength, the observed effect probably depending on
the nature of the analyte, as can be concluded from inver-
sions of migration orders. Compared to the aqueous
medium, NSAIDs could undergo a shift in their pKa values
in the methanolic buffer; this has been described previ-
ously for some acidic compounds [16]. A buffer with an
apparent pH of 8.5, which corresponds to a concentration
of 13.75 mM ammonia, allows for baseline resolution of
the mixture of the eleven NSAIDs contained in the test
mixture (see Fig. 4).
3.3 Temperature
Under the conditions described above, i.e., 50 mM ammo-
nium acetate and 13.75 mM ammonia in methanol (*pH
8.5) at 25oC, some of the 13 NSAIDs coelute, such as the
pairs suprofen-ketoprofen and indoprofen-sulindac. As
can be seen in Fig. 8, an increase in temperature leads to
a slight decrease in migration times for all NSAIDs, due to
a decrease in the viscosity of the separation medium.
Some changes of the migration order occur as the tem-
perature increases, resulting in improvement in resolu-
tion. Indoprofen migrates faster than sulindac at 25oC, but
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Figure 8. Influence of tempera-
ture on migration times. Buffer:
50 mM ammonium acetate –
13.75 mM ammonia (*pH 8.5) in
methanol. Other conditions as
described in Section 2.3. Analy-
tes: (^) niflumic acid; (&) flufe-
namic acid; (~) piroxicam; (´)
alclofenac; () tiaprofenic acid;
(*) flurbiprofen; (^) suprofen;
(+) ketoprofen; (*) naproxen;
(–) indomethacin; (~) carprofen;
(-) indoprofen; (&) sulindac.
Figure 9. Separation of NSAIDs
in nonaqueous buffer at 36oC.
Buffer: 50 mM ammonium ace-
tate – 13.75 mM ammonia (*pH
8.5) in methanol. Temperature,
36oC. Other conditions as de-
scribed in Section 2.3. Peaks:
1, niflumic acid; 2, flufenamic
acid; 3, piroxicam; 4, alclofenac;
5, tiaprofenic acid; 6, flurbipro-
fen; 7, suprofen; 8, ketoprofen;
9, naproxen; 10, indomethacin;
11, carprofen; 12, sulindac;
13, indoprofen.
these compounds coelute at 30oC, whereas sulindac
becomes more mobile than indoprofen above 30oC. This
inversion of migration order results in a resolution im-
provement from 1.2 at 25oC to 2.4 at 40oC. For the pair
suprofen-ketoprofen, the resolution increases from 1.2 at
25oC to 1.6 at 40oC. In contrast, for the pair naproxen –
indomethacin, which can be resolved with an Rs value of
4.1 at 25oC, the resolution decreases as the temperature
increases. Naproxen moves increasingly closer to indo-
methacin, and the two analytes coelute at 37oC. Figure 9
represents the separation of 13 NSAIDs at 36oC. This
temperature was found to be the best compromise for the
model mixture of NSAIDs, and allows a good separation
of 13 analytes in about 13 min. The effect of temperature
on the selectivity in this nonaqueous system provides an
additional parameter that may improve the separation of
analytes with similar charge densities which are difficult to
resolve even in nonaqueous media. However, it appears
from this study that the electrophoretic behavior of some
analytes is sensitive to very slight changes of tempera-
ture: an increase in temperature of only 1oC may have a
strong influence on resolution, as for example for the pair
naproxen-indomethacin. It appears from Fig. 9 that peak
shape and peak efficiency remain good at higher temper-
atures (average N: 113 000 at 25oC and 102 000 at
36oC). This observation indicates that Joule heating pro-
duced in nonaqueous systems is lower than with aqueous
buffers, making it possible to use higher temperatures in
nonaqueous systems without a significant loss of effi-
ciency, compared to aqueous buffers.
4 Concluding remarks
A nonaqueous electrolyte made of 50 mM ammonium
acetate and 13.75 mM ammonia in methanol was suited
to resolve eleven NSAIDs at 25oC and 13 NSAIDs at
36oC, without a modifier besides the methanol itself. The
same buffer containing 30% acetonitrile provides a satis-
factory separation for 13 NSAIDs at 35oC. The apparent
pH, the addition of acetonitrile, and temperature are
parameters which can be optimized for improvements of
selectivity in nonaqueous systems. Not all effects of
changes in absolute and relative migration times (selec-
tivity) observed in the reported experiments can be
explained. The use of nonaqueous electrolytes seems to
be an effective means to change and increase separation
selectivity in CE, especially for more hydrophobic analy-
tes with similar charge densities, which are often difficult
to resolve in aqueous media.
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